IGHE and hereditary angioedema: The 2021 revision and update of the international WAO/EAACI guideline for the management of hereditary angioedema classifies mast cell mediator-induced AE in IgE mediated and non-IgE mediated, and identifies the idiopathic forms as the conditions in which the mediator is unknown [2].